Concepedia

Anna‐Luisa Luger

AL

Statistics

Publications

12

Citations

417

H-Index

11

Active since

2018

Affiliations

Goethe University Frankfurt(Current)

University Hospital Frankfurt

Frankfurt Cancer Institute

Deutsches Konsortium für Translationale Krebsforschung

Heidelberg University

Anna‐Luisa Luger is an author at Goethe University Frankfurt specializing in oncology, cancer metabolism, and medicine.

ORCID

Publications per year

2018–2024

12

Publications

12

Serine-dependent redox homeostasis regulates glioblastoma cell survival

Anna L. Engel, Nadja I. Lorenz, Kevin Klann et al. · British Journal of Cancer · 2020 · 86 citations · Full text

, , +17

The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma

Martha Foltyn, Anna‐Luisa Luger, Nadja I. Lorenz et al. · British Journal of Cancer · 2019 · 79 citations · Full text

, , +17

Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems

Anna‐Luisa Luger, Benedikt Sauer, Nadja I. Lorenz et al. · International Journal of Molecular Sciences · 2018 · 45 citations · Full text

, , +15

Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet

Nadja I. Lorenz, Anna‐Luisa Luger, Joachim P. Steinbach et al. · International Journal of Molecular Sciences · 2018 · 33 citations · Full text

, , +16

Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide

Nadja I. Lorenz, Alina C. M. Sittig, Hans Urban et al. · Scientific Reports · 2021 · 33 citations · Full text

, , +17

1–5 of 12